Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
58.10
-0.81 (-1.38%)
Jan 23, 2025, 12:08 PM EST - Market open
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $1.78 billion as of January 23, 2025. Its market cap has increased by 53.01% in one year.
Market Cap
1.78B
Enterprise Value
1.73B
1-Year Change
53.01%
Ranking
Category
Stock Price
$57.78
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $1.78B, an increase of 1,134.13%. That is a compound annual growth rate of 150.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2025 | 1.82B | -6.64% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.19B |
| UnitedHealth Group | 477.79B |
| Novo Nordisk | 360.47B |
| Johnson & Johnson | 348.55B |
| AbbVie | 300.33B |
| Merck & Co. | 242.57B |
| Thermo Fisher Scientific | 220.02B |
| Intuitive Surgical | 217.47B |